Showing 1471-1480 of 7932 results for "".
Advanced Systemic Therapeutics
https://practicaldermatology.com/topics/skin-cancer-photoprotection/advanced-systemic-therapeutics/18755/By Seemal R. Desai, MD and Neal Bhatia, MD, FAADFrom updates in infectious disease to hormonal therapies, and off-label uses of biologics, the key to successful treatment is matching mechanisms to disease states. Dr. Bhatia explains.How to Eliminate Frown Lines
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/how-to-eliminate-frown-lines/18793/Laguna Niguel skin doctor, Lita Gelgur, MD provides information on treating frown lines on your forehead.Considerations for Treatment Downtime After Laser Therapy in Scar Repair
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/considerations-for-treatment-downtime-after-laser-therapy-in-scar-repair-/18625/E. Victor Ross, MD discusses how treatment downtime influences his approach for treating scars. His goal, he said, is to achieve the highest degree of efficacy possible with laser used as mono- or combination therapy while being mindful of patients' comfort levels with the associated recovery periodCosmetic Surgery Forum 2015 Highlights
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/cosmetic-surgery-forum-2015-highlights/18659/Covering topics from the appropriate use of permanent fillers to the role of spirituality in practice, the seventh annual Cosmetic Surgery Forum (CSF) brought together experts from multiple specialties at the Aria in Las Vegas this month. The three-day program included guidance on practice managemenEnstilar Approved; New Data for Otezla, Duac
https://practicaldermatology.com/topics/psoriasis/dermwiretv-enstilar-approved-new-data-for-otezla-duac/18687/LEO Pharma's Enstilar (Calcipotriene and Betamethasone Dipropionate) Foam, 0.005%/0.064% has been FDA-approved for plaque psoriasis. New data presented at EADV on Stiefel's Duac, Celgene's Otezla, and Boehringer Ingelheim's investigational biologic compound BI 655066. Plus, Galderma's OTC Excipial lColor Your World
https://practicaldermatology.com/topics/practice-management/color-your-world/18833/The colors you use in your office and the style of your space-and your staff outfits-can all influence the perception of you and your practice. Heidi Waldorf, MD tells you how to give your space the attention it needs.The State of Academic Dermatology
https://practicaldermatology.com/topics/practice-management/the-state-of-academic-dermatology/18843/In this edition of Derm Insider, host Neal Bhatia, MD sits down with Jane Grant-Kels, MD, Sheila Fallon Friedlander, MD, and Kevin Cooper, MD to discuss the challenges and rewards of academic dermatology. From meeting aggressive budgets to dealing with EMRs, academicians face many of the same demandDermwireTV — Bayer Buys Merck’s OTC Lines, Allergan Rejects Valeant Bid
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-mdash-bayer-buys-merck-rsquo-s-otc-lines-allergan-rejects-valeant-bid/19134/Bayer Purchases Merck's OTC Products and Allergan Rebuffs Valeant. This week DermWireTV explores Bayer's growth in the OTC space, including sunscreens, and reports new data on skin cancer mortality. Also in this edition: Neal Bhatia, MD reviews the Noah Worcester Society Annual Meeting.Laser Tattoo Removal and the Use of Stacked Treatments
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/laser-tattoo-removal-and-the-use-of-stacked-treatments/19309/Tattoo removal procedures have been offered since the late 1990's, but are more effective than ever. This improvement is due to the implementation of stack treatments, during which four sessions can be performed at one time. To show the advances in this procedure, Dr. Joel Schlessinger walks you thrSocial Media: Mass Med Society
https://practicaldermatology.com/topics/practice-management/mass-med-society/19360/Massachusetts Medical Society: Social Media Pitfalls and Opportunities, including inadvertent disclosure and security.